1. Home
  2. BMI vs GRFS Comparison

BMI vs GRFS Comparison

Compare BMI & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BMI
  • GRFS
  • Stock Information
  • Founded
  • BMI 1905
  • GRFS 1940
  • Country
  • BMI United States
  • GRFS Spain
  • Employees
  • BMI N/A
  • GRFS N/A
  • Industry
  • BMI Industrial Machinery/Components
  • GRFS Biotechnology: Pharmaceutical Preparations
  • Sector
  • BMI Industrials
  • GRFS Health Care
  • Exchange
  • BMI Nasdaq
  • GRFS Nasdaq
  • Market Cap
  • BMI 7.2B
  • GRFS 6.2B
  • IPO Year
  • BMI N/A
  • GRFS 2006
  • Fundamental
  • Price
  • BMI $188.86
  • GRFS $10.60
  • Analyst Decision
  • BMI Buy
  • GRFS Hold
  • Analyst Count
  • BMI 7
  • GRFS 1
  • Target Price
  • BMI $239.33
  • GRFS $10.30
  • AVG Volume (30 Days)
  • BMI 514.7K
  • GRFS 1.3M
  • Earning Date
  • BMI 07-22-2025
  • GRFS 01-01-0001
  • Dividend Yield
  • BMI 0.72%
  • GRFS N/A
  • EPS Growth
  • BMI 19.85
  • GRFS 132.60
  • EPS
  • BMI 4.59
  • GRFS 0.53
  • Revenue
  • BMI $873,926,000.00
  • GRFS $8,744,226,659.00
  • Revenue This Year
  • BMI $13.14
  • GRFS $5.40
  • Revenue Next Year
  • BMI $8.86
  • GRFS $6.74
  • P/E Ratio
  • BMI $41.14
  • GRFS $25.53
  • Revenue Growth
  • BMI 11.82
  • GRFS 9.32
  • 52 Week Low
  • BMI $162.17
  • GRFS $6.19
  • 52 Week High
  • BMI $256.08
  • GRFS $11.14
  • Technical
  • Relative Strength Index (RSI)
  • BMI 31.52
  • GRFS 64.29
  • Support Level
  • BMI $182.66
  • GRFS $10.41
  • Resistance Level
  • BMI $190.95
  • GRFS $10.82
  • Average True Range (ATR)
  • BMI 6.10
  • GRFS 0.30
  • MACD
  • BMI 0.22
  • GRFS -0.03
  • Stochastic Oscillator
  • BMI 31.22
  • GRFS 66.46

About BMI Badger Meter Inc.

Badger Meter Inc is an innovator, manufacturer, and marketer of products incorporating flow measurement, quality, control, and other system solutions serving markets. The company's products measure water, oil, chemicals, and other fluids, and provide and communicate timely measurement data. Its product lines include two categories: sales of water meters, radios, software, and related technologies, and water quality monitoring solutions to water utilities (utility water) and sales of meters and other sensing instruments, valves, software, and other solutions for industrial applications in water, wastewater, and other industries (flow instrumentation). It derives a majority of its revenues from the United States.

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

Share on Social Networks: